Single-cell transcriptomic profiling identifies YY1 as a key regulator of fibroblast plasticity in hypertrophic scar formation

Abstract

Background: Hypertrophic scars (HTSs) are characterized by excessive extracellular matrix deposition and impaired scar remodelling. Fibroblasts are central to HTS pathogenesis, yet clinical strategies remain limited by an incomplete understanding of fibroblast heterogeneity and transcriptional regulation. This study aimed to identify a key fibroblast subpopulation and its regulatory transcription factors to address this translational gap. Methods: Single-cell RNA sequencing was performed on dermal cells from freshly excised human HTS and normal skin (NS) tissues. Fibroblast subsets and transcriptional regulators were identified using Seurat, pseudotime, transcription factor prediction, and cell–cell communication analyses. Functional validation involved lentiviral overexpression of Yin Yang 1 (YY1) in fibroblasts derived from patients with hypertrophic scars, followed by bulk RNA sequencing, western blotting, CUT&Tag, and immunofluorescence assays. Results: Clinical HTS specimens showed characteristic collagen overproduction and vascular hyperplasia. Single-cell analysis of 43 303 cells revealed disease-specific shifts in cellular composition, including pronounced pericyte expansion and reduced fibroblast abundance. Notably, fibroblast subcluster Fib_5 (ADAM12⁺COMP⁺POSTN^hi) increased despite the overall fibroblast decline in HTS and exhibited upregulated fibrotic gene expression. Cross-validation using combined public datasets comprising 21 samples indicated that the Fib_5-like subcluster is conserved across fibrotic conditions. Pseudotime analyses placed Fib_5 within an HTS-dominant branch, State 6; transcription factor prediction from branch-dependent differentially expressed genes identified YY1 as the only predicted transcription factor also differentially expressed in State 6. Functional validation showed that YY1 overexpression in fibroblasts derived from patients with HTS reversed fibrotic gene expression profiles, with Fib_5 identified as a primary responder by Scissor. CUT&Tag analysis validated these findings at the epigenomic level. Cell–cell communication analyses further revealed marked reprogramming of fibroblast-pericyte signalling across multiple fibrosis-related pathways in HTS. Conclusion: This work establishes the Fib_5-YY1 axis as a central hub in HTS pathogenesis, with YY1-mediated fibroblast plasticity as a key transcriptional mechanism underlying skin fibrogenesis.

Keywords

Single-cell RNA sequencing / Hypertrophic scar / Fibroblast plasticity / Transcription factor / Yin Yang 1 / Fibrosis / Extracellular matrix

References

[1] Liu M, Liu X, Zhang J, Liang S, Gong Y, Shi S, et al. Single-cell RNA sequencing reveals the heterogeneity of myofibroblasts in wound repair. Genomics 2025; 117: 110982. https://doi.org/10.1016/j.ygeno.2024.110982.

[2] Xie S, Huang R, Qian W, Ding X, Zhang W, Li Y, et al. Globotriaosylceramide Gb3 influences wound healing and scar formation by orchestrating fibroblast heterogeneity. Adv Sci Weinh Baden-Wurtt Ger 2025; 12: e09733. https://doi.org/10.1002/advs.202509733.

[3] Yao H, Jing SL, Huang KX, Griffin MF, Longaker MT, Wan DC, et al. Clinical features and mechanisms of differential wound healing and scarring across anatomical sites. Adv Wound Care published online 10 Nov 2025. https://doi.org/10.1177/21621918251387627.

[4] Griffin M, Guo JL, Parker JBL, Kuhnert M, Li DJ, Valencia C, et al. Multi-omic analysis reveals retinoic acid molecular drivers for dermal fibrosis and regenerative repair in the skin. Cell Stem Cell 2025; 32: 1421-1437.e6. https://doi.org/10.1016/j.stem.2025.07.010.

[5] Cheng X, Gao Z, Shan S, Shen H, Zheng H, Jin L, et al. Single cell transcriptomics reveals the cellular heterogeneity of keloids and the mechanism of their aggressiveness. Commun Biol 2024; 7: 1-12. https://doi.org/10.1038/s42003-024-07311-1.

[6] Bodnar RJ, Satish L, Yates CC, Wells A. Pericytes: a newly recognized player in wound healing. Wound Repair Regen 2016; 24: 204-14. https://doi.org/10.1111/wrr.12415.

[7] Liu X, Chen W, Zeng Q, Ma B, Li Z, Meng T, et al. Single-cell RNA-sequencing reveals lineage-specific regulatory changes of fibroblasts and vascular endothelial cells in keloids. J Invest Dermatol 2022; 142: 124-135.e11. https://doi.org/10.1016/j.jid.2021.06.010.

[8] Wang Y, Zhou X, Liu M, Huang M, Chen P, Li X, et al. Targeting NRP1 in endothelial cells facilitates the normalization of scar vessels and prevents fibrotic scarring. Adv Sci Weinh Baden-Wurtt Ger 2025; 13: e10545. https://doi.org/10.1002/advs.202510545.

[9] Hong YK, Lin YC, Cheng TL, Lai CH, Chang YH, Huang YL, et al. TEM1/endosialin/CD248 promotes pathologic scarring and TGF-β activity through its receptor stability in dermal fibroblasts. J Biomed Sci 2024; 31: 12. https://doi.org/10.1186/s12929-024-01001-0.

[10] Zhang S, Zhang Y, Min P. Single-cell and bulk transcriptome data integration reveals dysfunctional cell types and aberrantly expressed genes in hypertrophic scar. Front Genet 2021; 12: 806740. https://doi.org/10.3389/fgene.2021.806740.

[11] Zhao S, Xie J, Zhang Q, Ni T, Lin J, Gao W, et al. New antifibrotic strategies for keloids: insights from single-cell multi-Omics. Cell Prolif 2025; 58: e13818. https://doi.org/10.1111/cpr.13818.

[12] Deng W, Ma Y, Su Z, Liu Y, Liang P, Huang C. et al. Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma. Mol Ther Oncolytics 2021; 20: 105-18. https://doi.org/10.1016/j.omto.2020.12.003.

[13] Han C, Yuan H, Koh TJ, Chen L, Mecham RP, DiPietro LA. Loss of MFAP5 and its effect on skin homeostasis and wound healing. FASEB J 2025; 39: e71273. https://doi.org/10.1096/fj.202501770R.

[14] Yu Q, Dai Q, Huang Z, Li C, Yan L, Fu X, et al. Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A/ETV4 axis. J Transl Med 2023; 21: 231. https://doi.org/10.1186/s12967-023-04065-y.

[15] Zhong XC, Chen CY, Feng ZX, Wang Y, Zhang T, Zhuang ZM, et al. Hsa_circ_0026782 acts as a ‘molecular break’ of CREB1-mediated transcription by promoting its phosphorylation at Ser142 that prevents keloid progression. Adv Sci Weinh Baden-Wurtt Ger 2025; 12: e08647. https://doi.org/10.1002/advs.202508647.

[16] McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst 2019; 8: 329-337.e4. https://doi.org/10.1016/j.cels.2019.03.003.

[17] Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM III, et al. Comprehensive integration of single-cell data. Cell 2019; 177: 1888-1902.e21. https://doi.org/10.1016/j.cell.2019.05.031.

[18] Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol 2012; 16: 284-7. https://doi.org/10.1089/omi.2011.0118.

[19] Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019; 10: 1523. https://doi.org/10.1038/s41467-019-09234-6.

[20] Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 2019; 566: 496-502. https://doi.org/10.1038/s41586-019-0969-x.

[21] Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res 2018; 46: D380-6. https://doi.org/10.1093/nar/gkx1013.

[22] Sun D, Guan X, Moran AE, Wu LY, Qian DZ, Schedin P, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol 2022; 40: 527-38. https://doi.org/10.1038/s41587-021-01091-3.

[23] Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc 2025; 20: 180-219. https://doi.org/10.1038/s41596-024-01045-4.

[24] Solé-Boldo L, Raddatz G, Schütz S, Mallm JP, Rippe K, Lonsdorf AS, et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol 2020; 3: 188. https://doi.org/10.1038/s42003-020-0922-4.

[25] Kim J, Lee J, Kim HJ, Kameyama N, Nazarian R, der E, et al. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J Allergy Clin Immunol 2021; 148: 1281-92. https://doi.org/10.1016/j.jaci.2021.04.021.

[26] Vorstandlechner V, Laggner M, Copic D, Klas K, Direder M, Chen Y, et al. The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation. Nat Commun 2021; 12: 6242. https://doi.org/10.1038/s41467-021-26495-2.

[27] Direder M, Weiss T, Copic D, Vorstandlechner V, Laggner M, Pfisterer K, et al. Schwann cells contribute to keloid formation. Matrix Biol J Int Soc Matrix Biol 2022; 108: 55-76. https://doi.org/10.1016/j.matbio.2022.03.001.

[28] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550. https://doi.org/10.1186/s13059-014-0550-8.

[29] Chen Y, Lun ATL, Smyth GK. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res 2016; 5: 1438.

[30] Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, et al. CUT&tag for efficient epigenomic profiling of small samples and single cells. Nat Commun 2019; 10: 1930. https://doi.org/10.1038/s41467-019-09982-5.

[31] Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinf (Oxf) 2018; 34: i884-90. https://doi.org/10.1093/bioinformatics/bty560.

[32] Md V, Misra S, Li H, Aluru S. Efficient Architecture-Aware Acceleration of BWA-MEM for Multicore Systems. In 2019 IEEE Int Parallel Distrib Process Symp (IPDPS), Brazil, Rio de Janeiro, 2019, 314-24.

[33] Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008; 9: R137. https://doi.org/10.1186/gb-2008-9-9-r137.

[34] Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010; 38: 576-89. https://doi.org/10.1016/j.molcel.2010.05.004.

[35] Yu G, Wang LG, He QY. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinf (Oxf) 2015; 31: 2382-3. https://doi.org/10.1093/bioinformatics/btv145.

[36] Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinf (Oxf) 2010; 26: 841-2. https://doi.org/10.1093/bioinformatics/btq033.

[37] Tuleta I, Frangogiannis NG. Pericytes in tissue fibrosis. Am J Physiol Cell Physiol 2025; 329: C868-86. https://doi.org/10.1152/ajpcell.00403.2025.

[38] van Splunder H, Villacampa P, Martínez-Romero A, Graupera M. Pericytes in the disease spotlight. Trends Cell Biol 2024; 34: 58-71. https://doi.org/10.1016/j.tcb.2023.06.001.

[39] L Alex, I Tuleta, SC Hernandez, A Hanna, H Venugopal, M Astorkia, et al. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction. Circulation 2023; 148: 882-98. https://doi.org/10.1161/CIRCULATIONAHA.123.064155.

[40] Zhao Z, Zhang Y, Zhang C, Zhang J, Luo X, Qiu Q, et al. TGF-β promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways. Exp Mol Med 2022; 54: 673-84. https://doi.org/10.1038/s12276-022-00778-0.

[41] Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci 2016; 113: E5618-27. https://doi.org/10.1073/pnas.1608384113.

[42] Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-27. https://doi.org/10.2353/ajpath.2008.080433.

[43] Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97. https://doi.org/10.2353/ajpath.2010.090517.

[44] Li Y, Li C, Liu W, Gao T, Liu Q, Yang L, et al. Single-cell RNA sequencing reveals fibroblast heterogeneity and identifies CLOCK as a key regulator in fibrotic skin diseases. Sci Rep 2025; 16: 786. https://doi.org/10.1038/s41598-025-30260-6.

[45] Lambert SA, Jolma A, Campitelli LF, das PK, Yin Y, Albu M, et al. The human transcription factors. Cell 2018; 175: 598-9. https://doi.org/10.1016/j.cell.2018.09.045.

[46] Doeser MC, Schöler HR, Wu G. Reduction of fibrosis and scar formation by partial reprogramming In vivo. Stem Cells 2018; 36: 1216-25. https://doi.org/10.1002/stem.2842.

[47] Wang J, Du J, Song Y, Tan X, Wu J, Wang T, et al. CILP1 interacting with YBX1 promotes hypertrophic scar formation by suppressing PPARs transcription. Cell Death Dis 2025; 16: 371. https://doi.org/10.1038/s41419-025-07554-8.

[48] Martins Peçanha FL, Jaafar R, Werneck-de-Castro JP, Apostolopolou CC, Bhushan A, Bernal-Mizrachi E. The transcription factor YY1 is essential for Normal DNA repair and cell cycle in human and mouse β-cells. Diabetes 2022; 71: 1694-705. https://doi.org/10.2337/db21-0908.

[49] Ou X, Huo J, Huang Y, Li YF, Xu S, Lam KP. Transcription factor YY1 is essential for iNKT cell development. Cell Mol Immunol 2019; 16: 547-56. https://doi.org/10.1038/s41423-018-0002-6.

[50] Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, et al. YY1 is a structural regulator of enhancer-promoter loops. Cell 2017; 171: 1573-1588.e28. https://doi.org/10.1016/j.cell.2017.11.008.

[51] Jin J, Wang K, Lu C, Yao C, Xie F. YY1-induced long noncoding RNA HOXA11-AS activates oxidative stress and inflammation by epigenetic modification of Nrf2 pathway to promote keloid formation. Redox Rep Commun Free Radic Res 2025; 30: 2539030. https://doi.org/10.1080/13510002.2025.2539030.

[52] Yang T, Shu F, Yang H, Heng C, Zhou Y, Chen Y, et al. YY1: a novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis. Metabolism 2019; 96: 33-45. https://doi.org/10.1016/j.metabol.2019.04.013.

[53] Chen L, Yang Y, Peng X, Yan H, Zhang X, Yin L, et al. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis. Aging 2020; 12: 8339-51. https://doi.org/10.18632/aging.103142.

[54] Tan CY, Wong JX, Chan PS, Tan H, Liao D, Chen W, et al. Yin Yang 1 suppresses dilated cardiomyopathy and cardiac fibrosis through regulation of Bmp7 and Ctgf. Circ Res 2019; 125: 834-46. https://doi.org/10.1161/CIRCRESAHA.119.314794.

[55] Huang Y, Li L, Chen H, Liao Q, Yang X, Yang D, et al. The protective role of Yin-Yang 1 in cardiac injury and Remodeling after myocardial infarction. J Am Heart Assoc 2021; 10: e021895. https://doi.org/10.1161/JAHA.121.021895.

[56] Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, et al. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Investig J Tech Methods Pathol 2020; 100: 801-11. https://doi.org/10.1038/s41374-020-0404-9.

[57] Liu M, Ning X, Li R, Yang Z, Yang X, Sun S, et al. Signalling pathways involved in hypoxia-induced renal fibrosis. J Cell Mol Med 2017; 21: 1248-59. https://doi.org/10.1111/jcmm.13060.

[58] Wu L, Zhang Q, Mo W, Feng J, Li S, Li J, et al. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. Sci Rep 2017; 7: 9289. https://doi.org/10.1038/s41598-017-09673-5.

[59] Xu Y, Wang X, Han D, Wang J, Luo Z, Jin T, et al. Revealing the mechanism of Jiegeng decoction attenuates bleomycin-induced pulmonary fibrosis via PI3K/Akt signaling pathway based on lipidomics and transcriptomics. Phytomed Int J Phytother Phytopharm 2022; 102: 154207. https://doi.org/10.1016/j.phymed.2022.154207.

[60] Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022; 7: 78. https://doi.org/10.1038/s41392-022-00925-z.

[61] Liu J, Yan J, Qi S, Zhang J, Zhang X, Zhao Y. The PI3K/AKT/mTOR pathway in scar remodeling and keloid formation: mechanisms and therapeutic perspectives. Front Pharmacol 2025; 16: 1678953. https://doi.org/10.3389/fphar.2025.1678953.

[62] Hays E, Bonavida B. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 2019; 43: 10-28. https://doi.org/10.1016/j.drup.2019.04.001.

[63] Yang P, Li J, Peng C, Tan Y, Chen R, Peng W, et al. TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K-AKT axis in colorectal cancer. Clin Transl Med 2020; 10: e211. https://doi.org/10.1002/ctm2.211.

[64] Zhou S, Qu KL, Li JA, Chen SL, Zhang YG, Zhu C, et al. YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis. Cancer Cell Int 2021; 21: 699. https://doi.org/10.1186/s12935-021-02328-6.

[65] Song Y, Guo B, Ma S, Chang P, Tao K. Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt. Biomed Pharmacother 2018; 105: 1291-8. https://doi.org/10.1016/j.biopha.2018.06.103.

[66] Wu X, Wang Z, Wu G, Xu X, Zhang J, Li Y, et al. Tetramethylpyrazine induces apoptosis and inhibits proliferation of hypertrophic scar-derived fibroblasts via inhibiting the phosphorylation of AKT. Front Pharmacol 2020; 11: 602. https://doi.org/10.3389/fphar.2020.00602.

[67] Li Y, Zhang J, Zhou Q, Wang H, Xie S, Yang X, et al. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. Exp Dermatol 2019; 28: 19-27. https://doi.org/10.1111/exd.13800.

[68] Pi Z, Qiu X, Liu J, Shi Y, Zeng Z, Xiao R. Activating Protein-1 (AP-1): a promising target for the treatment of fibrotic diseases. Curr Med Chem 2023; 31: 904-18. https://doi.org/10.2174/0929867330666230209100059.

[69] Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-70. https://doi.org/10.1038/nm.2848.

[70] Crawford J, Nygard K, Gan BS, O’Gorman DB. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring. Exp Dermatol 2015; 24: 120-6. https://doi.org/10.1111/exd.12601.

[71] Yokota K, Kobayakawa K, Saito T, Hara M, Kijima K, Ohkawa Y, et al. Periostin promotes scar formation through the interaction between Pericytes and infiltrating monocytes/macrophages after spinal cord injury. Am J Pathol 2017; 187: 639-53. https://doi.org/10.1016/j.ajpath.2016.11.010.

[72] Jeon KI, Nehrke K, Huxlin KR. Semaphorin 3A potentiates the profibrotic effects of transforming growth factor-β1 in the cornea. Biochem Biophys Res Commun 2020; 521: 333-9. https://doi.org/10.1016/j.bbrc.2019.10.107.

[73] De Angelis Rigotti F, Wiedmann L, Hubert MO, Vacca M, Hasan SS, Moll I, et al. Semaphorin 3C exacerbates liver fibrosis. Hepatol Baltim Md 2023; 78: 1092-105. https://doi.org/10.1097/HEP.0000000000000407.